跳至主要内容
临床试验/NCT05030766
NCT05030766已完成4 期

A Pilot SMART Pre- and Post-testing of an Integrative Mindfulness-Based Smoking Cessation Intervention for HIV Patients

University of Miami1 个研究点 分布在 1 个国家目标入组 95 人开始时间: 2022年1月4日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
95
试验地点
1
主要终点
Number of Participants Reporting 7-day Point-prevalence Abstinence

研究概览

简要总结

The purpose of this study is to examine the feasibility, acceptability and effect of a combined smoking cessation intervention integrating contingency management (reward-based) strategies with Mindfulness training to identify the optimal dynamic strategy to promote smoking cessation among HIV patients.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Sequential
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosed with HIV (based on self-report).
  • Be 18 years and older
  • Have smoked ≥ 5 cigarettes/day in the past year
  • Be interested in making a quit attempt in the next 30 days
  • Own a smartphone (apple/android), and plan to keep it active for the next 6 months
  • Able to consent
  • Have no plans to move in the next 6 months
  • Are not pregnant or planning to be pregnant in the following 6 months
  • Have any condition that, in the opinion of the investigator, would compromise the well-being of the patient or the study or prevent the patient from meeting or performing study requirements

排除标准

  • Have contraindication to NRT (past month myocardial infarction, history of serious arrhythmias/or unstable angina pectoris, dermatological disorder)
  • Are currently being treated for a psychiatric condition.
  • Are currently being treated for smoking cessation, alcoholism, or illicit drug use
  • Are adults unable to consent
  • Are individuals who are not yet adults
  • Are pregnant women
  • Are prisoners

研究组 & 干预措施

MT plus NRT Group-Phase 1

Experimental

Participants who receive the Mindfulness Training (MT) intervention for 4 weeks in addition to 6 weeks of Nicotine Replacement Therapy (NRT).These participants are responders (have quit smoking at the 1 month follow up) or non-responders (those who have not quit smoking at the 1 month follow up) and randomized to receive no additional intervention.

干预措施: Nicotine Replacement Therapy (Drug)

MT plus NRT Group-Phase 1

Experimental

Participants who receive the Mindfulness Training (MT) intervention for 4 weeks in addition to 6 weeks of Nicotine Replacement Therapy (NRT).These participants are responders (have quit smoking at the 1 month follow up) or non-responders (those who have not quit smoking at the 1 month follow up) and randomized to receive no additional intervention.

干预措施: Mindfulness Training Smoking Cessation Intervention (Behavioral)

CM plus NRT Group-Phase1

Experimental

Participants who receive the Contingency Management (CM) intervention for 4 weeks in addition to 6 weeks of NRT. These participants are responders (have quit smoking at the 1 month follow up) or non-responders (those who have not quit smoking at the 1 month follow up) and randomized to receive no additional intervention.

干预措施: Nicotine Replacement Therapy (Drug)

CM plus NRT Group-Phase1

Experimental

Participants who receive the Contingency Management (CM) intervention for 4 weeks in addition to 6 weeks of NRT. These participants are responders (have quit smoking at the 1 month follow up) or non-responders (those who have not quit smoking at the 1 month follow up) and randomized to receive no additional intervention.

干预措施: Contingency Management Smoking Cessation Intervention (Behavioral)

MT plus NRT with additional CM Group-Phase2

Experimental

Participants who received the MT intervention for 4 weeks with 6 weeks of NRT and are non-responders (those who have not quit smoking at the 1 month follow up) and randomized to receive an additional CM intervention for another 4 weeks.

干预措施: Nicotine Replacement Therapy (Drug)

MT plus NRT with additional CM Group-Phase2

Experimental

Participants who received the MT intervention for 4 weeks with 6 weeks of NRT and are non-responders (those who have not quit smoking at the 1 month follow up) and randomized to receive an additional CM intervention for another 4 weeks.

干预措施: Mindfulness Training Smoking Cessation Intervention (Behavioral)

MT plus NRT with additional CM Group-Phase2

Experimental

Participants who received the MT intervention for 4 weeks with 6 weeks of NRT and are non-responders (those who have not quit smoking at the 1 month follow up) and randomized to receive an additional CM intervention for another 4 weeks.

干预措施: Contingency Management Smoking Cessation Intervention (Behavioral)

CM plus NRT with additional MT Group-Phase2

Experimental

Participants who received the CM intervention for 4 weeks with 6 weeks of NRT and are non-responders (those who have not quit smoking at the 1 month follow up) and randomized to receive an additional MT intervention for another 4 weeks.

干预措施: Nicotine Replacement Therapy (Drug)

CM plus NRT with additional MT Group-Phase2

Experimental

Participants who received the CM intervention for 4 weeks with 6 weeks of NRT and are non-responders (those who have not quit smoking at the 1 month follow up) and randomized to receive an additional MT intervention for another 4 weeks.

干预措施: Mindfulness Training Smoking Cessation Intervention (Behavioral)

CM plus NRT with additional MT Group-Phase2

Experimental

Participants who received the CM intervention for 4 weeks with 6 weeks of NRT and are non-responders (those who have not quit smoking at the 1 month follow up) and randomized to receive an additional MT intervention for another 4 weeks.

干预措施: Contingency Management Smoking Cessation Intervention (Behavioral)

结局指标

主要结局

Number of Participants Reporting 7-day Point-prevalence Abstinence

时间窗: 4 weeks (end of treatment), and 3 months

Defined as self-report of not smoking in the past 7-days, not even a puff and confirmed by expired carbon monoxide (CO) level cutoff of \< 8 ppm using a coVita iCO™ Smokerlyzer® and/or NicoTests saliva sample of ≤ 30 ng/mL.

次要结局

  • Retention Rate(3 months)
  • Treatment Specific Adherence Rates(3 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Taghrid Asfar

Research Assistant Professor

University of Miami

研究点 (1)

Loading locations...

相似试验

Testing Integrative Smoking Cessation for HIV... | 临床试验